Breaking News Instant updates and real-time market news.

NVS

Novartis

$72.00

-0.835 (-1.15%)

, PM

Philip Morris

$91.08

-0.1521 (-0.17%)

10:47
01/04/17
01/04
10:47
01/04/17
10:47

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan analyst Richard Vosser downgraded Novartis (NVS) to Neutral from Overweight saying pressures on the company's business are mounting. The pressure from generic erosion in 2017 "remains high" with an estimated $2.3B of sales expected to be lost to generics, said Vosser, who sees "significant downside" to consensus estimates for Novartis. 2. BofA Merrill Lynch analyst Lisa Lewandowski downgraded Philip Morris (PM) to Neutral from Buy and lowered its price target to $96 from $102 citing concerns from the strong U.S. dollar, less impact from an overhaul in U.S. tax policy versus peers, underperformance in combustible tobacco volumes, increasing heat-not-burn competition, a rotation out of defensive/bond proxy assets, and debt convent constraints. 3. Jefferies analyst Andy Barish downgraded Dunkin' Brands (DNKN) to Underperform from Hold, saying he does not believe the company's same-store-sales have broken out above 2% while its international growth has been disappointing. Barish also downgraded Cheesecake Factory (CAKE) to Underperform, citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. 4. Evercore ISI downgraded Intuitive Surgical (ISRG) to Hold from Buy and lowered its price target to $690 from $780, with analyst Vijay Kumar saying he expects 2017 to be one of the most challenging for healthcare in general, with the sector facing issues ranging from ACA repeal to border tax reform to interest expense deductibility. 5. Cowen analyst Helane Becker downgraded a number of airline stocks, including United Continental (UAL), JetBlue (JBLU), Alaska Air (ALK) and American Airlines (AAL), to Market Perform from Outperform based on valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NVS

Novartis

$72.00

-0.835 (-1.15%)

PM

Philip Morris

$91.08

-0.1521 (-0.17%)

DNKN

Dunkin' Brands

$52.30

-0.14 (-0.27%)

CAKE

Cheesecake Factory

$59.43

-0.45 (-0.75%)

ISRG

Intuitive Surgical

$641.79

7.62 (1.20%)

UAL

United Continental

$73.24

0.53 (0.73%)

AAL

American Airlines

$46.30

-0.39 (-0.84%)

JBLU

JetBlue

$22.39

-0.03 (-0.13%)

ALK

Alaska Air

$88.71

0.71 (0.81%)

  • 19

    Jan

  • 01

    Feb

  • 21

    Feb

NVS Novartis
$72.00

-0.835 (-1.15%)

01/04/17
JPMS
01/04/17
DOWNGRADE
JPMS
Neutral
Novartis downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Vosser downgraded Novartis to Neutral saying pressures on the company's business are mounting. The pressure from generic erosion in 2017 "remains high" with an estimated $2.3B of sales expected to be lost to generics, Vosser tells investors in a research note. He sees "significant downside" to consensus estimates for Novartis.
12/20/16
RHCO
12/20/16
NO CHANGE
RHCO
Conatus price target raised to $26 from $17 at SunTrust
After Conatus (CNAT) announced a partnership deal with Novartis (NVS), SunTrust analyst John Boris says the deal is "transformational" for Conatus. The analyst thinks that the deal will be worth about $1B to Conatus. He believes that the deal makes strategic sense to Conatus because of the potential synergies in the mechanism of action between its NASH treatment and that of Novartis (NVS). Boris keeps a Buy rating on Conatus.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/03/17
JPMS
01/03/17
DOWNGRADE
JPMS
Neutral
Novartis downgraded to Neutral from Overweight at JPMorgan
PM Philip Morris
$91.08

-0.1521 (-0.17%)

12/19/16
WELS
12/19/16
NO CHANGE
WELS
Likelihood of Altria Group acquisition has increased, says Wells Fargo
Wells Fargo says that the chances of Philip Morris (PM) acquiring Altria Group (MO) in the next 6-12 months have increased to 70%. The firm cites several reasons for its view, including what it sees as the increased attractiveness of the U.S. market, global consolidation in the sector, and its belief that the value of Philip Morris' smokeless cigarettes will increase if it acquires Altria. The firm keeps Outperform ratings on both stocks and names Altria its new top stock pick.
11/16/16
STFL
11/16/16
NO CHANGE
Target $110
STFL
Buy
Philip Morris pullback creates 'exceptional' opportunity, says Stifel
Stifel analyst Christopher Growe says the recent pullback in shares of Philip Morris has created an "an exceptional opportunity for investors." The stock weakness "fully misses" the company's strong underlying growth, Growe tells investors in a research note. He believes Philip's free cash flow is fully supportive of the nearly 5% dividend yield. Growe reiterates a Buy rating on Philip Morris with a $110 price target.
01/04/17
BOFA
01/04/17
DOWNGRADE
Target $96
BOFA
Neutral
Philip Morris downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Lisa Lewandowski downgraded Philip Morris to Neutral and lowered its price target to $96 from $102 citing concerns from the strong US dollar, less impact from an overhaul in US tax policy versus peers, underperformance in combustible tobacco volumes, increasing heat-not-burn competition, a rotation out of defensive/bond proxy assets, and debt convent constraints.
11/14/16
11/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he is pleased with the company's comments regarding its 2018 free cash flow outlook, and he thinks that it could benefit from increased defense spending in the wake of the election results. 2. Philip Morris (PM) upgraded to Buy from Outperform at CLSA with analyst Michael Levy citing the recent pullback for his rating change and said he sees the company adding to its buyback. 3. Citi (C) upgraded to Overweight from Equal Weight at Morgan Stanley with analysts led by Betsy Graseck saying the Republican sweep is positive for all financial stocks due to increased growth, higher rates, lower taxes, and less regulation. 4. U.S. Steel (X) and AK Steel (AKS) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. L Brands (LB), Kohl's (KSS), and Chico's(CHS) were upgraded to Buy from Neutral at Citi, while Chico's was also upgraded to Outperform from Peer Perform at Wolfe Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DNKN Dunkin' Brands
$52.30

-0.14 (-0.27%)

12/19/16
BMOC
12/19/16
NO CHANGE
BMOC
Dunkin' Brands could be acquired for $65-$75 per share, says BMO Capital
After Bloomberg reported that JAB Holdings could look to buy Dunkin' Brands, BMO Capital analyst AndrewStrelzik estimates that the company could be acquired for $65-$75 per share, based on JAB's other deals in the sector in recent years. However, he says that he's "uncertain" whether the deal will occur and keeps a Market Perform rating on the shares.
12/15/16
MAXM
12/15/16
NO CHANGE
Target $61
MAXM
Buy
Dunkin' Brands price target raised to $61 from $57 at Maxim
Maxim analyst Stephen Anderson said his recent round of channel checks lead him to believe the launch of Dunkin' Donuts locations inside BJ's clubs is off to a solid start. He also thinks cold brew coffee platform extension can possibly drive comp sales in 2017 and that a reversal in coffee prices should reduce pressure on franchisees to raise menu prices. He raised his price target on Dunkin' shares to $61 from $57 and keeps a Buy rating on the stock.
12/14/16
12/14/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dunkin' Brands (DNKN) initiated with a Market Perform at Cowen. 2. Sonic (SONC) initiated with a Market Perform at Cowen. 3. Advance Auto Parts (AAP) was initiated with an Overweight at Atlantic Equities while the firm initiated AutoZone (AZO), Genuine Parts (GPC), and O'Reilly Automotive (ORLY) with a Neutral. 4. Blackhawk (HAWK) initiated with a Buy at Craig-Hallum. 5. Evercore Partners (EVR) initiated with a Neutral at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/17
JEFF
01/04/17
DOWNGRADE
Target $45
JEFF
Underperform
Dunkin' Brands downgraded to Underperform from Hold at Jefferies
Jefferies analyst Andy Barish downgraded Dunkin' Brands to Underperform saying he does not believe the company's same-store-sales have broken out above 2% while its international growth has been disappointing. The analyst keeps a $45 price target for the shares.
CAKE Cheesecake Factory
$59.43

-0.45 (-0.75%)

11/16/16
SPHN
11/16/16
DOWNGRADE
SPHN
Equal Weight
Cheesecake Factory downgraded to Equal Weight from Overweight at Stephens
01/04/17
JEFF
01/04/17
DOWNGRADE
Target $51
JEFF
Underperform
Cheesecake Factory downgraded to Underperform from Hold at Jefferies
Jefferies analyst Andy Barish downgraded Cheesecake Factory to Underperform citing the 15% post-election rally with no change in fundamentals along with the company's "significant" mall exposure. The analyst keeps a $51 price target for the shares.
11/15/16
11/15/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. FedEx (FDX) downgraded to Hold from Buy at Stifel with analyst David Ross citing valuation, as well as concerns about the "still-fragile global economic environment" and the integration of its TNT acquisition. 2. Abercrombie & Fitch (ANF) downgraded to Underperform at FBR Capital while the firm also downgraded American Eagle (AEO) to Market Perform from Outperform. 3. Amplify Snack Brands (BETR) downgraded to Perform from Outperform at Oppenheimer and to Neutral from Outperform at Credit Suisse. 4. BP (BP) downgraded to Outperform from Buy at CLSA while the firm also downgraded ConocoPhillips (COP) to Underperform from Outperform. 5. Cheesecake Factory (CAKE) downgraded to Hold from Buy at Maxim with analyst Stephen Anderson saying he sees the company's above-peer comps, market share gains, and solid new unit development prospects as being priced in after the 22% jump in the stock from its late October low. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/16
JPMS
12/19/16
NO CHANGE
JPMS
JPMorgan says sell Casual Dining names after recent rally
JPMorgan analyst John Ivankoe believes fundamentals in the Casual Dining space have not improved as much as the current stock prices suggest. He recommends fading the rally across the sector, even the names he rates Overweight. Ivankoe has Neutral ratings on Darden (DRI), Cheesecake Factory (CAKE), Texas Roadhouse (TXRH) and Fogo De Chao (FOGO) and Overweight ratings on Brinker (EAT) and Bloomin' Brands (BLMN). Supply growth in the Casual Dining space is increasing across the industry faster than demand while commodity cost benefits are moderating, Ivankoe tells investors in a research note.
ISRG Intuitive Surgical
$641.79

7.62 (1.20%)

01/04/17
EVER
01/04/17
DOWNGRADE
EVER
Hold
Intuitive Surgical downgraded to Hold from Buy at Evercore ISI
10/19/16
EVER
10/19/16
NO CHANGE
Target $785
EVER
Buy
Intuitive Surgical weakness a buying opportunity says Evercore ISI
Evercore ISI analyst Vijay Kumar said Intuitive Surgical's Q3 print reaffirmed his view that Xi upgrade cycle is on a nice adoption cycle and higher consumable revenue per procedure was a very positive sign. Further, the analyst believes underlying margin trends were strong ex one-time items and thinks nothing fundamentally has changed regarding the company's medium term outlook. Kumar recommends buying the post Q3 weakness and reiterates his Buy rating and $785 price target.
10/19/16
LEER
10/19/16
NO CHANGE
Target $810
LEER
Outperform
Intuitive Surgical price target raised to $810 from $790 at Leerink
Leerink analyst Richard Newitter raised his price target for Intuitive Surgical to $810 from $790 on higher estimates and cash position, following the company's Q3 revenue and EPS beat, which was marked by solid year over year procedure growth and gross margin outperformance. The analyst remains bullish on Intuitive Surgical amid an improving procedure and gross margin outlook plus new product launches in the near-term. Newitter reiterates an Outperform rating on the shares.
01/04/17
01/04/17
DOWNGRADE

Hold
Intuitive Surgical downgraded to Hold on macro uncertainties at Evercore ISI
As previously reported, Evercore ISI downgraded Intuitive Surgical to Hold from Buy and lowered its price target to $690 from $780. Analyst Vijay Kumar expects 2017 to be one of the most challenging for healthcare in general, with the sector facing issues ranging from ACA repeal to border tax reform to interest expense deductibility. Kumar thinks the uncertainty among the customer base is likely to have an impact on all big ticket items, including robotic surgery.
UAL United Continental
$73.24

0.53 (0.73%)

12/15/16
LEHM
12/15/16
INITIATION
Target $105
LEHM
Overweight
United Continental initiated with an Overweight at Barclays
Barclays analyst Brandon Oglenski started United Continental with an Overweight rating and $105 price target. The analyst calls United his top pick in the space.
01/04/17
COWN
01/04/17
DOWNGRADE
Target $75
COWN
Market Perform
United Continental downgraded to Market Perform from Outperform at Cowen
Cowen analyst Helane Becker downgraded United Continental to Market Perform from Outperform based on valuation. Becker lowered her price target to $75 from $77 on United Continental shares.
12/06/16
12/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pandora (P) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying a combination with Sirius XM (SIRI) makes sense at $18-$21 per share. 2. Netflix (NFLX) upgraded to Hold from Sell at Evercore ISI with analyst Ken Sena saying much of the competition he had feared has gained little traction. 3. Starbucks (SBUX) upgraded to Buy from Hold at Edward Jones. 4. United Continental (UAL) upgraded to Buy from Neutral at BofA/Merrill with analyst Andrew Didora saying United 's low margins relative to the group give it the most upside to a economic recovery while its corporate hub focus will benefit from improving business conditions and better than expected GDP. 5. Nucor (NUE) upgraded to Buy from Hold at Berenberg with Alessandro Abate saying higher steel prices and expectations for stronger volumes, combined with OPEC's decision to curb oil output, underpin momentum for the U.S. steel industry long-term and offset risks of a pullback. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/16
12/06/16
UPGRADE
Target $85

Buy
United Continental upgraded on increased GDP optimism at BofA/Merrill
As previously reported, BofA/Merrill upgraded United Continental to Buy and raised its price target to $85 from $68. Analyst Andrew Didora said United 's low margins relative to the group give it the most upside to a economic recovery while its corporate hub focus will benefit from improving business conditions and better than expected GDP.
AAL American Airlines
$46.30

-0.39 (-0.84%)

01/04/17
COWN
01/04/17
DOWNGRADE
Target $50
COWN
Market Perform
American Airlines downgraded to Market Perform from Outperform at Cowen
Cowen analyst Helane Becker downgraded American Airlines to Market Perform from Outperform based on valuation. Becker reiterated her $50 price target on American Airlines shares.
11/18/16
11/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cisco (CSCO) coverage resumed with a Hold at Stifel. 2. UPS (UPS) was initiated with an Outperform at BMO Capital while the firm initiated FedEx (FDX) with a Market Perform. 3. Synchrony (SYF) was initiated with an Overweight at Stephens. The firm also initiated American Express (AXP) and Discover (DFS) with an Underweight. 4. American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and Allegiant Travel (ALGT) were initiated with a Buy at Citi while the firm initiated JetBlue (JBLU), United Continental (UAL), Alaska Air (ALK), and Hawaiian Holdings (HA) with a Neutral. 5. Juniper (JNPR) coverage resumed at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/15/16
LEHM
12/15/16
INITIATION
Target $62
LEHM
Equal Weight
American Airlines initiated with an Equal Weight at Barclays
Barclays analyst Brandon Oglenski started American Airlines with an Equal Weight rating and $62 price target.
11/18/16
SBSH
11/18/16
INITIATION
Target $55
SBSH
Buy
American Airlines initiated with a Buy at Citi
Citi analyst Kevin Crissey started American Airlines with a Buy rating and $55 price target. The analyst calls American his top pick in the sector. He sees potential upside in unit revenue due to slower competitive capacity growth.
JBLU JetBlue
$22.39

-0.03 (-0.13%)

01/04/17
COWN
01/04/17
DOWNGRADE
Target $23
COWN
Market Perform
JetBlue downgraded to Market Perform from Outperform at Cowen
Cowen analyst Helane Becker downgraded JetBlue to Market Perform from Outperform based on valuation. Becker maintained her $23 price target on JetBlue shares.
12/15/16
LEHM
12/15/16
INITIATION
Target $33
LEHM
Overweight
JetBlue initiated with an Overweight at Barclays
Barclays analyst Brandon Oglenski started JetBlue with an Overweight rating and $33 price target.
12/21/16
12/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Stifel with analyst Astrachan citing "recent negative FX movement, moderate anticipated input cost inflation, and continued heightened geopolitical uncertainty." 2. JetBlue (JBLU) downgraded to Market Perform from Outperform at Raymond James with analyst Savanthi Syth saying shares will be range bound near-term due to RASM pressures from capacity growth new market expansion, and increased cost inflation. 3. Barrick Gold (ABX) downgraded to Hold from Buy at TD Securities analyst Greg Barnes saying shares have significantly outperformed in 2016 and sees fewer company-specific catalysts in 2017. 4. New York Community Bancorp (NYCB) and Astoria Financial (AF) were downgraded to Underperform at FBR Capital. 5. Goldman Sachs (GS) and U.S. Bancorp (USB) were downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/21/16
RAJA
12/21/16
DOWNGRADE
RAJA
Market Perform
JetBlue downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Savanthi Syth downgrading shares of JBLU to Market Perform saying shares will be range bound near-term due to RASM pressures from capacity growth new market expansion, and increased cost inflation. Syth lowered estimates given the near-term relative headwinds and sees balanced risk-reward.
ALK Alaska Air
$88.71

0.71 (0.81%)

01/04/17
COWN
01/04/17
DOWNGRADE
Target $95
COWN
Market Perform
Alaska Air downgraded to Market Perform from Outperform at Cowen
Cowen analyst Helane Becker downgraded Alaska Air to Market Perform from Outperform based on valuation. Becker raised her price target to $95 from $92 on Alaska Air shares.
12/15/16
LEHM
12/15/16
INITIATION
LEHM
Overweight
Alaska Air initiated with an Overweight at Barclays
Barclays analyst Brandon Oglenski started Alaska Air with an Overweight rating and $122 price target.
12/07/16
JPMS
12/07/16
DOWNGRADE
Target $57
JPMS
Underweight
Virgin America downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Jamie Baker downgraded Virgin America (VA) to Underweight after the company's takeover by Alaska Air (ALK) received regulatory approval. The analyst has a $57 price target for the shares and increased target of $93.50 for Overweight-rated Alaska Air.

TODAY'S FREE FLY STORIES

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

AVXL

Anavex

$5.88

-0.06 (-1.01%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on Anavex »

Anavex files to sell 5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.